Hangzhou Biotest Biotech (688767.SH) releases a forecasted increase, with an estimated net profit of 170 million yuan in 2024, a year-on-year increase of 59.47%.
Bot Bio (688767.SH) announced that the company expects to achieve net profit attributable to the parent company in 2024...
Hangzhou Biotest Biotech (688767.SH) announced that the company expects to achieve a net profit attributable to the owners of the parent company of approximately 170 million yuan in the year 2024. Compared with the same period last year (according to statutory disclosure data), it will increase by approximately 63.3942 million yuan, an increase of about 59.47% year-on-year.
Related Articles
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Hims & Hers Health (HIMS.US) launches cheap weight loss pills, FDA stops sales the next day, stock price plummets after hours.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Hims & Hers Health (HIMS.US) launches cheap weight loss pills, FDA stops sales the next day, stock price plummets after hours.
